-
ELOXD share price: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
ELOXD stock price change: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
ELOXD market open/close: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
Key terms
About ELOXD
Eloxx Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of novel ribonucleic acid-modulating drug candidates. It focuses on the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Arlington, MA.
-
Market cap: $260.01K
A market capitalization up to $300 million places ELOXD in the micro-capitalization category.
Key terms
Smart score
Latest ELOXD news
No recent TipRanks articles are available for ELOXD
No recent press releases are available for ELOXD
ELOXD Financials
-
ELOXD total revenue: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
ELOXD net income: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
ELOXD earnings per share: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
Key terms
ELOXD Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ELOXD Competitors
-
How competitors are chosen
ELOXD's competitors are included in the Health Technology sector and Biotechnology group
-
Market cap: $260.01K
A market capitalization up to $300 million places ELOXD in the micro-capitalization category.
